Data are sparse for COVID-19 and Aspergillus co-infections
March 30 2020
Invasive pulmonary aspergillosis is a well-known complication of severe influenza, but it is not yet clear whether it could be a major co-infection in COVID-19 cases.
Loss of taste with terbinafine the most common side effect - FDA reports
March 23 2020
Wang & Lipman analysed 26 years' worth of adverse event reports made to the FDA for several antifungals, and found that taste disturbance was most common for terbinafine (12%).
Sexual problems and recurrent vulvovaginal candidiasis (rVVC)
March 11 2020
Recurrent vulvovaginal candidiasis (rVVC) is an unpleasant condition surrounded by taboos. Two new studies (one in Iran, one in São Paulo/New York) found lower quality of life and higher rates of depression among sufferers
Mucormycosis - 21 month, 12 centre prospective study in India finds 52% mortality
March 09 2020
A survey of 465 mucormycosis cases in India found a mortality rate of 52% over 90 days, and diabetes was the most important underlying condition in 74%
Neglected diseases, market failures, public health failures
February 26 2020
Fungal disease are often neglected, despite causing significant morbidity and mortality. A new review by Marcio Rodrigues and Joshua Nosanchuk highlights areas for improvement including availability and affordability of antifungals, improved diagnostics and better engagement by public health organisations.